Seeking Alpha

Allergan (AGN +1.3%) saw a bounce in its Botox migraine share last month, according to Wells...

Allergan (AGN +1.3%) saw a bounce in its Botox migraine share last month, according to Wells Fargo. The firm says research data for February shows it with an 8.8% market share among sample neurologists, up from 5.3% in January and 8.4% in December. Wells estimates U.S. sales are close to $300M annually, tracking ahead of estimates. The firm maintains its Outperform rating on the stock.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|